Skip to main content

Table 1 Clinical characteristics of study participants

From: Case finding for sarcopenia in geriatric inpatients: performance of bioimpedance analysis in comparison to dual X-ray absorptiometry

  Total, n (%) Female, n (%) Male, n (%) p valuec
Number of participants 60 (100) 42 (70) 18 (30)  
Age (y, mean ± SD) 81.6 ± 5.28 80.4 ± 5.29 84.5 ± 4.08 p = 0.005
Community dwelling 55 (92) 37 (88) 18 (100) n.s.
Malnutrition (MNA <17) 26 (43) 21 (50) 5 (28) n.s.
Obesity (BMI > 30 kg/m2) 14 (23) 10 (24) 4 (22) n.s.
Morbidity:     
 Coronary heart disease 18 (30) 9 (21) 9 (50) p = 0.035
 Chronic heart failure 16 (27) 9 (21) 7 (39) n.s.
 Cerebrovascular diseasea 20 (33) 11 (26) 9 (50) n.s.
 Art. Hypertension 49 (82) 35 (83) 14 (78) n.s.
 COPD 6 (10) 3 (7) 3 (17) n.s.
 Diabetes 16 (27) 11 (26) 5 (28) n.s.
 CKD (≥ stage 3) 22 (37) 12 (29) 10 (56) n.s.
 Cancerb 10 (17) 6 (14) 4 (22) n.s.
 Mild or moderate dementia 7 (12) 3 (7) 4 (22) n.s.
Comorbidity (≥2 of listed diseases) 46 (77) 30 (71) 16 (89) n.s.
Comorbidity (≥3 of listed diseases) 35 (58) 20 (48) 15 (83) p = 0.012
Polypharmacy (≥5 drugs taken) 48 (80) 33 (78) 15 (83) n.s.
Dependency in ADL (Barthel <70) 27 (45) 19 (45) 8 (44) n.s.
Gait speed [m/s] (mean ± SD) 0.86 ± 0.37 0.77 ± 0.34 1.05 ± 0.36 p = 0.005
Grip strength [kg] (mean ± SD) 24.8 ± 9.90 20.9 ± 7.36 33.6 ± 9.45 p < 0.001
  1. SD standard deviation, MNA Mini Nutritional Assessment, BMI Body Mass Index, CKD chronic kidney disease (stage 3 referring to a GFR < 60 ml/min/1.73 m2), ADL Activities of Daily Living
  2. aincludes also patients with a history of transient ischaemic attacks; b: includes patients with a history of malignancy independent of current evidence of active disease. cfor significance of differences between women and men, n.s., not significant (p > 0.05)